Search - tctmd.com

Displaying 81 - 100 of 178

Sort: Relevancy | Date

News Daily News

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

Todd Neale

July 22, 2020

News Daily News

Atrial Septal Aneurysm, Not Shunt Size, Tied to Recurrent PFO-Related Stroke

Yael L. Maxwell

May 04, 2020

News Daily News

In the Setting of PFO, Time to Retire ‘Cryptogenic’ Stroke

Yael L. Maxwell

April 16, 2020

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

L.A. McKeown

February 24, 2020

Presentation Live Valves 2019

TAVI: Cerebral Protection for Everyone

Presenter: Susheel Kodali

December 10, 2019

Presentation

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

December 02, 2019

Presentation Controversies and Advances 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presenter: Tarun Chakravarty

November 15, 2019

Presentation TCT Abstracts Posters 2019

Incidence, predictors and outcomes of periprocedural stroke in patients undergoing TAVR: Report from National Inpatient sample

Presenter: Moinuddin Syed

October 28, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Industry News

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

September 05, 2019

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Todd Neale

August 16, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Caitlin E. Cox

May 31, 2019

News Industry News

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

May 22, 2019

News Daily News

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Yael L. Maxwell

May 06, 2019

Advertisement

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

Atrial Septal Aneurysm, Not Shunt Size, Tied to Recurrent PFO-Related Stroke

In the Setting of PFO, Time to Retire ‘Cryptogenic’ Stroke

March 2020 News Roundup

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

TAVI: Cerebral Protection for Everyone

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Incidence, predictors and outcomes of periprocedural stroke in patients undergoing TAVR: Report from National Inpatient sample

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content